Patents Assigned to University of Essex Enterprises Ltd.
  • Publication number: 20190154694
    Abstract: The present invention relates to a method for diagnosing, evaluating the prognosis of a cancer patient and evaluating the aggressiveness of a cancer. The methods comprise detecting the phosphorylation status of a Scribble protein, a fragment or variant thereof, wherein the phosphorylation status is indicative of cancer, prognosis and the aggressiveness of a cancer. In one embodiment the cancer is breast cancer.
    Type: Application
    Filed: November 5, 2018
    Publication date: May 23, 2019
    Applicant: University of Essex Enterprises Ltd.
    Inventor: Metodi Vladimirov Metodiev
  • Publication number: 20160341733
    Abstract: The present invention relates to a method for diagnosing, evaluating the prognosis of a cancer patient and evaluating the aggressiveness of a cancer. The methods comprise detecting the phosphorylation status of a Scribble protein, a fragment or variant thereof, wherein the phosphorylation status is indicative of cancer, prognosis and the aggressiveness of a cancer. In one embodiment the cancer is breast cancer.
    Type: Application
    Filed: February 26, 2016
    Publication date: November 24, 2016
    Applicant: University of Essex Enterprises Ltd.
    Inventor: Metodi Vladimirov Metodiev
  • Patent number: 9310371
    Abstract: The present invention relates to a method for diagnosing, evaluating the prognosis of a cancer patient and evaluating the aggressiveness of a cancer. The methods comprise detecting the phosphorylation status of a Scribble protein, a fragment or variant thereof, wherein the phosphorylation status is indicative of cancer, prognosis and the aggressiveness of a cancer. In one embodiment the cancer is breast cancer.
    Type: Grant
    Filed: October 16, 2013
    Date of Patent: April 12, 2016
    Assignee: University of Essex Enterprises Ltd.
    Inventor: Metodi Vladimirov Metodiev
  • Publication number: 20150104809
    Abstract: The present invention relates to a method for diagnosing, evaluating the prognosis of a cancer patient and evaluating the aggressiveness of a cancer. The methods comprise detecting the phosphorylation status of a Scribble protein, a fragment or variant thereof, wherein the phosphorylation status is indicative of cancer, prognosis and the aggressiveness of a cancer. In one embodiment the cancer is breast cancer.
    Type: Application
    Filed: October 16, 2013
    Publication date: April 16, 2015
    Applicant: University of Essex Enterprises Ltd.
    Inventor: Metodi Vladimirov Metodiev